期刊文献+

晚期卵巢癌的化学治疗 被引量:3

暂未订购
导出
出处 《实用中西医结合临床》 2006年第3期89-91,共3页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献24

  • 1de Jongh FE,van Veen RN,Veltman SJ,et al.Weekly high-dose cisplatin is a feasible treament option:analysis on prognosic factors for toxicity in 400 patients[J].BJC,2003,88(8):1 199~1 206
  • 2Eltabbakh GH,Piver MS,Hempling RE,et al.Prolonged disease-free survival by maintenance chemotherapy among patients with recurrent platinum-sensitive ovarian cancer[J].Gynecol Oncol,1998,7(2):190~195
  • 3Umesaki N,Tandka T,Muso H,et al.Intermittent cisplatin therapy for stage Ⅲ ovarian cancer patients following clinical remission[J].Gynecol Obsete Invest,1999,47(2):139~ 143
  • 4Piccart MJ,Green JA,Lacave AJ,et al.Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer A randomized phase Ⅱ study of the European Organization for Research and Treatment of Cancer Gynecology Group[J].J Clin Oncol,2000,18(6):1 193~1 202
  • 5Pete I,Szantho A,Mayer A,et al.Experience in first-line chemotherapy with paclitaxel for the treatment of ovarian carcinomas[J].Orv Hetil,2003,144(19):919~924
  • 6Eisenhauer EA,ten Bokkel Huinink WW,Swenerton KD,et al.European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer:high-dose versus low-dose and long versus short infusion[J].J Clin Oncol,1994,12 (12):2 654~2 666
  • 7McGuir WP,Hoskins WJ,Brady MF,etal.Cyclophosphamide and cispltatin compared with paclitaxel and cisplatin in patients with stage111 and stagelV ovarian cancer[J].N Engl J Med,1996,334(1):1~6
  • 8Ozols RF.Update of the NCCN ovarian cancer practice guidelines[J].Oncology (Huntingt),1997,11 (11):95~105
  • 9Ota S,Sugiyama T,Komai K,et al.Weekly 1 hour paclitaxel infusion in patients with recurrent gynecological tumors:a pilot study[J].Jpn J Clin Oncol,2001,31(8):395~398
  • 10Ishikawa H,Nakanishi I,Nawa A,et al.3-hour infusion of singleagent paclitaxel for recurrent ovarian cancer[J].Int J Clin Oncol,2001,6(3):128~131

同被引文献18

  • 1潘一红,陶俊贞,吕荣伟,金芙蓉,林慧敏,周丹红,陶德友.吉西他滨联合卡铂在复发性上皮性卵巢癌治疗中的应用[J].上海交通大学学报(医学版),2011,31(4):481-483. 被引量:6
  • 2黄啸,蔡树模,汤洁,李子庭,臧荣余.综合性治疗复发性卵巢上皮性癌的疗效及预后分析[J].中华妇产科杂志,2004,39(9):602-605. 被引量:18
  • 3苏应宽,徐增祥,江森等.实用妇科学[M].山东科学技术出版社,1995:78.
  • 4TaySK,IlanchadranA,TanTY.First-linegemcitabineandcarboplatininadvancedovariancarcinoma:aphaseⅡstudy[J].ntJGynecolCancer,2007,17(2):350-358.
  • 5BelpommeD,KrakowskiI,BeauduinM,Gemcitabinecombinedwithcisplatinasfirst-linetreatmentinpatientswithepithelialovariancancer:aphaseⅡstudy[J].GynecolOncol,2003Oct,91(1):32-8.
  • 6GuptaSK,JohnS,NaikR.et,al.AmulticenterphaseⅡstudyofgemcitabine,paclitaxel,andcisplatininchemonaveadvancedovariancancer[J].GynecolOncol,2005Jul,98(1):134-40.
  • 7VillellaJ,MarchettiD,OdunsiK,et,al.Responseofcombinationplatinumandgemcitabinechemotherapyforrecurrentepithelialovariancarcinoma[J].2004Dec,95(3):539-45.
  • 8PectasidesD,PectasidesE,PapaxoinisG,et,al.Carboplatin/gemcitabinealternatingwithcarboplatin/pegylatedliposomaldoxorubicinandcarboplatin/cyclophosphamideinplatinum-refractory/resistantpaclitaxel-pretreatedovariancarcinoma[J].GynecolOncol,2010Jul,118(1):52-57.
  • 9Gruenigen VE,Huang HQ,Gil KM,et al.Acomparison of quality-of-life domains and clinical factors in ovarian cancer patients:agynecologic oncology group study. Journal of Pain and Symptom Management . 2010
  • 10PospískovóM,SpenerovóM,Pilka R,et al.Repeated chemosensi-tivity testing in patients with epithelial ovarian carcinoma. European Journal of Gynaecological Oncology . 2010

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部